News
Boehringer Ingelheim & Palatin Technologies ink global research collaboration and licensing pact to develop innovative therapy for retinal diseases: Ingelheim, Germany Wednesday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback